Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity
暂无分享,去创建一个
Y. Kawasawa | Harinder Singh | Z. Rahman | T. Cooper | R. Caricchio | Phillip P. Domeier | Sathi Babu Chodisetti | Adam J. Fike | Nicholas M. Choi | Chelsea Corradetti
[1] J. Buckner,et al. IL-6: a cytokine at the crossroads of autoimmunity. , 2018, Current opinion in immunology.
[2] G. Gibson,et al. Distinct Effector B Cells Induced by Unregulated Toll‐like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus , 2018, Immunity.
[3] Yoshiya Tanaka,et al. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus , 2018, Front. Immunol..
[4] Y. Kawasawa,et al. B-Cell-Intrinsic Type 1 Interferon Signaling Is Crucial for Loss of Tolerance and the Development of Autoreactive B Cells , 2018, Cell reports.
[5] S. Rahman,et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE , 2018, Nature Communications.
[6] C. Carmona-Rivera,et al. Accelerated model of lupus autoimmunity and vasculopathy driven by toll-like receptor 7/9 imbalance , 2018, Lupus Science & Medicine.
[7] A. Canivet,et al. TLR7 escapes X chromosome inactivation in immune cells , 2018, Science Immunology.
[8] M. Madaio,et al. Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity , 2018, The Journal of Immunology.
[9] D. Rawlings,et al. B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity , 2017, The Journal of experimental medicine.
[10] M. Cancro,et al. Signals that drive T-bet expression in B cells. , 2017, Cellular immunology.
[11] H. Hsu,et al. Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells , 2017, The Journal of Immunology.
[12] S. Sarantopoulos,et al. TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells , 2017, Front. Immunol..
[13] P. Marrack,et al. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity , 2017, The Journal of clinical investigation.
[14] Z. Rahman,et al. Spontaneous germinal centers and autoimmunity , 2017, Autoimmunity.
[15] E. Wherry,et al. Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells , 2016, The Journal of Immunology.
[16] U. Klein,et al. Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development , 2016, Proceedings of the National Academy of Sciences.
[17] X. Liao,et al. Chemokines and Chemokine Receptors in the Development of Lupus Nephritis , 2016, Mediators of inflammation.
[18] D. Rawlings,et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6 , 2016, The Journal of experimental medicine.
[19] Z. Rahman,et al. IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity , 2016, The Journal of experimental medicine.
[20] P. Marrack,et al. Age-Associated B Cells: A T-bet–Dependent Effector with Roles in Protective and Pathogenic Immunity , 2015, The Journal of Immunology.
[21] Shwetank,et al. Distinct and synergistic roles of FcγRIIB deficiency and 129 strain-derived SLAM family proteins in the development of spontaneous germinal centers and autoimmunity. , 2015, Journal of autoimmunity.
[22] G. Stark,et al. Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-κB Pathways by Concerted Recruitment of the Mediator Complex , 2015, Cell reports.
[23] Eugenia G. Giannopoulou,et al. Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation , 2015, Nature Immunology.
[24] M. Boedigheimer,et al. Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus , 2015, Arthritis & rheumatology.
[25] C. Putterman,et al. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis , 2015, Nature Reviews Nephrology.
[26] Xi Chen,et al. The Histone Methyltransferase Smyd2 Is a Negative Regulator of Macrophage Activation by Suppressing Interleukin 6 (IL-6) and Tumor Necrosis Factor α (TNF-α) Production , 2015, The Journal of Biological Chemistry.
[27] S. Akira,et al. B Cell–Intrinsic TLR7 Signaling Is Essential for the Development of Spontaneous Germinal Centers , 2014, The Journal of Immunology.
[28] A. Fairhurst,et al. Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment , 2014, Front. Pharmacol..
[29] U. Klein,et al. Germinal center B cell maintenance and differentiation are controlled by distinct NF-κB transcription factor subunits , 2014, The Journal of experimental medicine.
[30] C. Alpers,et al. Opposing Impact of B Cell–Intrinsic TLR7 and TLR9 Signals on Autoantibody Repertoire and Systemic Inflammation , 2014, The Journal of Immunology.
[31] P. Emery,et al. TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes☆ , 2014, Journal of autoimmunity.
[32] S. Sano,et al. Epicutaneous Application of Toll‐like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild‐Type Mice: A New Model of Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.
[33] A. DeFranco,et al. Requirement for MyD88 Signaling in B Cells and Dendritic Cells for Germinal Center Anti-Nuclear Antibody Production in Lyn-Deficient Mice , 2014, The Journal of Immunology.
[34] Eugenia G. Giannopoulou,et al. Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling. , 2013, Immunity.
[35] K. Morris,et al. Interferon-γ and systemic autoimmunity. , 2013, Discovery medicine.
[36] P. Marrack,et al. T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance , 2013, Proceedings of the National Academy of Sciences.
[37] M. Shlomchik,et al. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. , 2013, Immunity.
[38] J. Connolly,et al. B Cell TLR7 Expression Drives Anti-RNA Autoantibody Production and Exacerbates Disease in Systemic Lupus Erythematosus–Prone Mice , 2012, The Journal of Immunology.
[39] C. Mohan,et al. The Lupus-Prone NZM2410/NZW Strain–Derived Sle1b Sublocus Alters the Germinal Center Checkpoint in Female Mice in a B Cell–Intrinsic Manner , 2012, The Journal of Immunology.
[40] A. Davidson,et al. The Yaa Locus and IFN-α Fine-Tune Germinal Center B Cell Selection in Murine Systemic Lupus Erythematosus , 2012, The Journal of Immunology.
[41] S. Bolland,et al. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell–mediated autoimmunity , 2012, Proceedings of the National Academy of Sciences.
[42] M. Cancro,et al. Role of type I interferons in the activation of autoreactive B cells , 2012, Immunology and cell biology.
[43] P. Marrack,et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity. , 2011, Blood.
[44] R. Knight,et al. STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest , 2010, Cell cycle.
[45] C. Liu,et al. IFN Regulatory Factor 5 Is Required for Disease Development in the FcγRIIB−/−Yaa and FcγRIIB−/− Mouse Models of Systemic Lupus Erythematosus , 2009, The Journal of Immunology.
[46] M. Cook,et al. Dysregulation of germinal centres in autoimmune disease , 2009, Nature Reviews Immunology.
[47] C. Putterman,et al. Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease1 , 2009, The Journal of Immunology.
[48] Lionel B Ivashkiv,et al. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.
[49] P. Hertzog,et al. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus , 2009, Arthritis research & therapy.
[50] H. Ploegh,et al. Murine B Cell Response to TLR7 Ligands Depends on an IFN-β Feedback Loop1 , 2009, The Journal of Immunology.
[51] Cole Trapnell,et al. How to map billions of short reads onto genomes , 2009, Nature Biotechnology.
[52] M. Madaio,et al. Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation. , 2009, Arthritis and rheumatism.
[53] W. Leonard,et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice , 2009, Proceedings of the National Academy of Sciences.
[54] N. Kamatani,et al. Excessive Production of IFN-γ in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B1 , 2008, The Journal of Immunology.
[55] T. Means,et al. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. , 2008, Journal of the American Society of Nephrology : JASN.
[56] R. Tibshirani,et al. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. , 2008, The Journal of clinical investigation.
[57] S. Akira,et al. Murine Dendritic Cell Type I IFN Production Induced by Human IgG-RNA Immune Complexes Is IFN Regulatory Factor (IRF)5 and IRF7 Dependent and Is Required for IL-6 Production1 , 2007, The Journal of Immunology.
[58] Wentian Li,et al. Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus , 2006, PLoS medicine.
[59] S. Akira,et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. , 2006, Immunity.
[60] J. Shupe,et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. , 2006, Immunity.
[61] A. Ding,et al. MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA , 2006, Nature Immunology.
[62] A. Cappione,et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. , 2005, The Journal of clinical investigation.
[63] J. Banchereau,et al. IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black × New Zealand White)F1 but Not in BALB/c Mice1 , 2005, The Journal of Immunology.
[64] S. Dikman,et al. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. , 2002, Seminars in arthritis and rheumatism.
[65] G. Kelsoe,et al. Spontaneous formation of germinal centers in autoimmune mice , 2001, Journal of leukocyte biology.
[66] Neal N. Iwakoshi,et al. Plasma cell differentiation requires the transcription factor XBP-1 , 2001, Nature.
[67] A. Csiszar,et al. Increased interferon‐gamma (IFN‐γ), IL‐10 and decreased IL‐4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) , 2000, Clinical and experimental immunology.
[68] K. Blenman,et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[69] D. Kono,et al. Treatment of murine lupus with cDNA encoding IFN-γR/Fc , 2000 .
[70] G. Tsokos,et al. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. , 1999, Journal of immunology.
[71] A. Schwarting,et al. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. , 1998, Journal of immunology.
[72] B. Ryffel,et al. IFN-γ Receptor Deletion Prevents Autoantibody Production and Glomerulonephritis in Lupus-Prone (NZB × NZW)F1 Mice , 1998, The Journal of Immunology.
[73] B. Ryffel,et al. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. , 1998, Journal of immunology.
[74] D. Balomenos,et al. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. , 1998, The Journal of clinical investigation.
[75] B. Ryffel,et al. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon‐γ receptor inhibits the onset of glomerulonephritis , 1995, European journal of immunology.
[76] H. Mcdevitt,et al. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon , 1987, The Journal of experimental medicine.
[77] David Z. Chen,et al. METHOD Open Access , 2014 .
[78] A. Ding,et al. MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. , 2006, Nature immunology.
[79] J. Banchereau,et al. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. , 2005, Journal of immunology.
[80] D. Kono,et al. Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. , 2000, The Journal of clinical investigation.